PT934745E - Utilizacao de derivados de androsterona para a inibicao da ligacao do adn de ap-1 e a proliferacao do musculo liso das vias respiratorias - Google Patents

Utilizacao de derivados de androsterona para a inibicao da ligacao do adn de ap-1 e a proliferacao do musculo liso das vias respiratorias

Info

Publication number
PT934745E
PT934745E PT99200310T PT99200310T PT934745E PT 934745 E PT934745 E PT 934745E PT 99200310 T PT99200310 T PT 99200310T PT 99200310 T PT99200310 T PT 99200310T PT 934745 E PT934745 E PT 934745E
Authority
PT
Portugal
Prior art keywords
androstan
bromo
fluoro
beta
alpha
Prior art date
Application number
PT99200310T
Other languages
English (en)
Inventor
Thomas Preston Kennedy
Original Assignee
Charlotte Mecklenburg Hosp Aut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charlotte Mecklenburg Hosp Aut filed Critical Charlotte Mecklenburg Hosp Aut
Publication of PT934745E publication Critical patent/PT934745E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT99200310T 1998-02-04 1999-02-03 Utilizacao de derivados de androsterona para a inibicao da ligacao do adn de ap-1 e a proliferacao do musculo liso das vias respiratorias PT934745E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1878298A 1998-02-04 1998-02-04

Publications (1)

Publication Number Publication Date
PT934745E true PT934745E (pt) 2004-09-30

Family

ID=21789760

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99200310T PT934745E (pt) 1998-02-04 1999-02-03 Utilizacao de derivados de androsterona para a inibicao da ligacao do adn de ap-1 e a proliferacao do musculo liso das vias respiratorias

Country Status (8)

Country Link
EP (1) EP0934745B1 (pt)
JP (2) JP3895490B2 (pt)
AT (1) ATE265214T1 (pt)
AU (1) AU763307B2 (pt)
CA (1) CA2260584C (pt)
DE (1) DE69916672T2 (pt)
ES (1) ES2221297T3 (pt)
PT (1) PT934745E (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
AU2003269889B2 (en) * 2002-06-17 2007-04-19 Epigenesis Pharmaceuticals, Llc Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
CA2496867A1 (en) * 2002-08-28 2004-03-11 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment methods
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
ES2773079T3 (es) * 2010-02-08 2020-07-09 Shenzhen Evergreen Therapeutics Co Ltd Métodos para el uso de progestágeno como sensibilizador de glucocorticoides
US20110262502A1 (en) * 2010-02-08 2011-10-27 Prairie Pharmaceuticals LLC Pulmonary delivery of 17-hydroxyprogesterone caproate (17-hpc)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8306370D0 (sv) * 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4529548A (en) * 1984-05-07 1985-07-16 E. R. Squibb & Sons, Inc. 17β-(substituted thio)androstenes
JP2858046B2 (ja) * 1993-03-09 1999-02-17 ユニバーシティ オブ ユタ リサーチ ファウンデーション 組織損傷を有する個人の組織生活能力の消失の予防乃至は軽減のための製薬組成
ES2201101T3 (es) * 1994-04-05 2004-03-16 Celltech Therapeutics Limited Uso de inhibidores de sulfatasas de esteroides.
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US5859000A (en) * 1995-06-07 1999-01-12 University Of Utah Research Foundation Method for reducing mast cell mediated allergic reactions

Also Published As

Publication number Publication date
AU763307B2 (en) 2003-07-17
ES2221297T3 (es) 2004-12-16
EP0934745A1 (en) 1999-08-11
JP2000016939A (ja) 2000-01-18
CA2260584A1 (en) 1999-08-04
JP2006342180A (ja) 2006-12-21
DE69916672D1 (de) 2004-06-03
JP3895490B2 (ja) 2007-03-22
AU1469399A (en) 1999-04-01
DE69916672T2 (de) 2005-04-07
ATE265214T1 (de) 2004-05-15
CA2260584C (en) 2007-07-31
EP0934745B1 (en) 2004-04-28

Similar Documents

Publication Publication Date Title
IL154272A (en) Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
UA50792C2 (uk) 7<font face="Symbol">a</font>-(<font face="Symbol">x</font>-АМІНОАЛКІЛ)ЕСТРАТРИЄНИ ТА ФАРМАЦЕВТИЧНИЙ ПРЕПАРАТ, ЩО ЇХ МІСТИТЬ
KR880012633A (ko) C_17 내지 C_20 리아제 억제제로서 유용한 17β-(사이클로프로필아미노)안드로스트-5-엔-3β-올 및 관련 화합물
PT934745E (pt) Utilizacao de derivados de androsterona para a inibicao da ligacao do adn de ap-1 e a proliferacao do musculo liso das vias respiratorias
BR9807079A (pt) Composto de derivado de 16-hidróxi-11- (fenil substituìdo) - estra-4,9-dieno, uso de um composto, formulação farmacêutica, e processo para a preparação de um composto.
BR0008437A (pt) Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos
HUP0100102A2 (hu) Fenil-amino-alkilkarbonsav-származékok és fenil-amino-alkilkarbonsav-származékokat tartalmazó gyógyszerészeti készítmények
HUP9801158A2 (hu) Imidazolszármazékok és ilyen vegyületeket tartalmazó gyógyászati készítmények
NO823125L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-amino-naftalen-derivater
ATE241609T1 (de) 7-carboxylatische flavon derivate, verfahren zur herstellung und verwendung als heilmittel
NO20025392D0 (no) 2-substituerte pregna-1,3-5(10)-trien og chola-1,3,5(10)- trienderivater og deres biologiske aktivitet
DE3572814D1 (en) 1, 3-benzoxathiole derivatives, their use and their preparation
HUT42783A (en) Process for preparing steroid aromatase-inhibitors
TR200003877T2 (tr) İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri
RS51490B (sr) POSTUPAK ZA IZRADU 7α-METILSTEROIDA
DE69903346D1 (de) 22s-hydroxycholesta-8,14-dien derivate mit meiose regulierende aktivität
BR9910859A (pt) Derivados de cianoiminoquinoxalina
NZ594085A (en) Tetrahydronaphthalen-2-ol derivatives
FR2703681B1 (fr) Procede de preparation de fluoro-6-halogeno-2 quinoleine